Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News JOHNSON & JOHNSON JNJ

Healthcare
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

Recent & Breaking News (NYSE:JNJ)

A Peek Into The Markets: U.S. Stock Futures Down Ahead Of Earnings

Benzinga.com  July 19, 2016

Investors Cheer Johnson & Johnson's Q2 Results

Benzinga.com  July 19, 2016

Keep an Eye on These 12 Stocks for July 19, 2016

Benzinga.com  July 19, 2016

Johnson & Johnson Dividend Offers 2.6% Yield

Benzinga.com  July 18, 2016

Can NFLX Grow its Subscriber Base?

Benzinga.com  July 18, 2016

Bank Earnings Keep Coming In New Week, But Economic Data Flow to Slow

Benzinga.com  July 18, 2016

The Market In 5 Minutes: Earnings Season Is Upon Us

Benzinga.com  July 18, 2016

A Shark Of An ETF In The Dividend ETF Tank

Benzinga.com  July 18, 2016

A Shark Of An ETF In The Dividend ETF Tank

Benzinga.com  July 18, 2016

Gilead Sciences Get European Commission Grant For Marketing Authorization Of Its Single Tablet Regimen Odefsey

Benzinga.com  June 23, 2016

A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of Yellen Speech

Benzinga.com  June 22, 2016

Johnson & Johnson Names Joseph Wolk As VP Of Investor Relations In Place Of Louise Mehrotra

Benzinga.com  June 22, 2016

JPMorgan On Tesla/SolarCity Deal: 'You Can't Put The Genie Back Into The Bottle'

Benzinga.com  June 22, 2016

Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice President of Investor Relations

PR Newswire June 22, 2016

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

PR Newswire June 21, 2016

5 Pharmaceutical Price Target Raises from Jefferies

Benzinga.com  June 14, 2016

4 Key Takeaways From ASCO

Benzinga.com  June 6, 2016

Preview Of Lululemon's Q1 Earnings: Margin Recapture Remains In Focus

Benzinga.com  June 6, 2016

Johnson & Johnson Partners with Leading Organizations to Advance Education of Young Women and Girls in Science, Technology, Engineering, Math, Manufacturing and Design (STEM2D)

PR Newswire June 6, 2016

The Market In 5 Minutes: Draghi, iPhones And Warriors

Benzinga.com  June 2, 2016